Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

Todd Neale

December 06, 2024

News Daily News

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Yael L. Maxwell

November 27, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

Presentation TCT 2024

TCT 668: Use of Antiplatelet Agents in Patients With Myocardial Bridge: Insights From the RIALTO Registry

Presenter: Domenico D'Amario

October 27, 2024

News Daily News

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Michael O'Riordan

October 10, 2024

News Conference News ESC 2024

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

Yael L. Maxwell

September 10, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Conference News ESOC 2024

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

Todd Neale

May 16, 2024

News Daily News

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Yael L. Maxwell

May 03, 2024

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Shelley Wood

April 06, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Daily News

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

L.A. McKeown

February 13, 2024

News Daily News

DAPT Works When Started Up to 3 Days After Mild Stroke, TIA

Todd Neale

January 04, 2024

Advertisement

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

TCT 668: Use of Antiplatelet Agents in Patients With Myocardial Bridge: Insights From the RIALTO Registry

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Scientific Statement Reviews Current Antithrombotic Options in PAD

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

What’s Going to Be Hot at ACC 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

DAPT Works When Started Up to 3 Days After Mild Stroke, TIA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content